Medicare Enrolled

Dr. Todd Zelczak, O.D.

Optometrist · Cincinnati, OH
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
Speaking/Promotional
8211 CORNELL RD, Cincinnati, OH 45249
5135300440
In practice since 2006 (19 years)
NPI: 1922195775 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Zelczak from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Zelczak? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Zelczak

Dr. Todd Zelczak is an optometrist in Cincinnati, OH, with 19 years of NPI registration. Based on federal Medicare data, Dr. Zelczak performed 1,325 Medicare services across 1,097 unique beneficiaries.

Between the years covered by Open Payments, Dr. Zelczak received a total of $20,615 from 37 pharmaceutical and/or device companies across 267 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in optometrist. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Zelczak is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 19 years in practice ▲ Top 14% volume in OH $20,615 industry payments

Medicare Practice Summary

Medicare Utilization ↗
1,325
Medicare services
Top 14% in OH for optometrist
1,097
Unique beneficiaries
$40
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~70 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Visual field test, extended
A test that maps your complete field of vision to detect blind spots or peripheral vision loss. Extended testing provides a more detailed assessment than a standard visual field exam.
243 $38 $120
Comprehensive eye exam, established patient
A comprehensive examination of the visual system performed for a patient who has previously been seen by the provider.
234 $76 $165
Office visit, established patient (10-19 min)
An office visit for an existing patient lasting 10 to 19 minutes. The visit involves medical evaluation and management of the patient's condition.
192 $38 $90
Imaging of front third of eye
Imaging of the front third of the eye.
153 $18 $125
Optic nerve imaging (OCT scan)
Imaging of the optic nerve.
152 $22 $100
Eye drainage system examination
An examination of the internal drainage system of the eye to assess how fluid flows and drains from the eye.
73 $15 $60
Retinal imaging (OCT scan)
This procedure involves imaging the retina to visualize its structure. It is used to examine the back of the eye.
73 $25 $100
Retinal photography (fundus photo)
This procedure involves taking photographs of the retina, the light-sensitive tissue at the back of the eye. It is used to document the condition of the eye's interior structures.
73 $22 $130
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
45 $53 $120
Eye exam, established patient, focused
A limited examination of the visual system for an existing patient. The provider focuses on a specific eye-related concern or symptom.
44 $56 $115
Ultrasound of eye using water bath method
An ultrasound imaging test of the eye that uses a water bath technique to visualize internal eye structures.
23 $36 $225
Comprehensive eye exam, new patient
A comprehensive examination of the visual system performed for a new patient.
20 $95 $195
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$20,615
Total received (2018-2024)
Avg $2,945/year across 7 years
Top 1% in OH for optometrist
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
37
Companies
267
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$13,890 (67.4%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$6,190 (30.0%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$534 (2.6%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$2,842
2023
$1,145
2022
$1,157
2021
$1,090
2020
$2,238
2019
$2,523
2018
$9,621

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Bausch & Lomb Americas Inc.
$1,993
Tarsus Pharmaceuticals, Inc.
$293
Harrow Eye, LLC
$157
SUN PHARMACEUTICAL INDUSTRIES INC.
$107
Thea Pharma Inc.
$86
Oyster Point Pharma, Inc.
$77
Glaukos Corporation
$62
Dompe US, Inc.
$23
ABBVIE INC.
$23
Ocular Therapeutix, Inc.
$20
Top 3 companies account for 86.0% of 2024 payments
All-time payments by company (2018-2024) ›
Shire North American Group Inc
$7,254
Bausch & Lomb Americas Inc.
$2,232
Bausch & Lomb, a division of Bausch Health US, LLC
$2,084
Allergan, Inc.
$2,059
Aerie Pharmaceuticals, Inc.
$1,756
Sun Pharmaceutical Industries Inc.
$793
Allergan Inc.
$688
Novartis Pharmaceuticals Corporation
$643
Oyster Point Pharma, Inc.
$591
Tarsus Pharmaceuticals, Inc.
$293
SUN PHARMACEUTICAL INDUSTRIES INC.
$280
Kala Pharmaceuticals, Inc.
$272
ABBVIE INC.
$179
Dompe US, Inc.
$176
Johnson & Johnson Vision Care, Inc.
$164
Harrow Eye, LLC
$157
Ivantis, Inc
$143
Johnson & Johnson Surgical Vision, Inc.
$124
Thea Pharma Inc.
$108
Horizon Therapeutics plc
$66
CooperVision Inc.
$62
Glaukos Corporation
$62
Alcon Vision LLC
$56
AbbVie Inc.
$52
EYEVANCE PHARMACEUTICALS LLC
$49
Ocular Therapeutix, Inc.
$47
Eyevance Pharmaceuticals LLC
$37
BioTissue Holdings, Inc.
$33
Visioneering Technologies, Inc.
$25
BIOTISSUE HOLDINGS, INC.
$22
Mallinckrodt Enterprises LLC
$21
Alcon Laboratories Inc
$16
Mallinckrodt LLC
$16
Sight Sciences, Inc.
$16
NovaBay Pharmaceuticals, Inc.
$14
Akorn, Inc.
$13
MacuLogix, Inc.
$13
Top 3 companies account for 56.1% of all-time payments
Associated products mentioned in payments ›
ACTHAR · ALPHAGAN P · Acuvue · AdaptDx · Avenova · BESIVANCE · BIOTRUE · BIOTRUE ONE DAY · BROMSITE · CEQUA · Cequa · Clariti Contact Lens · DAILIES · DEXTENZA · DURYSTA · EYSUVIS · Flarex · Hydrus Microstent · ILUX · INFUSE · INVELTYS · IYUZEH · LOTEMAX · LOTEMAX SM · LUMIGAN · MIEBO · Multiple Brands Contact Lens · MyDay Contact Lens · OXERVATE · Oxervate · PROKERA · RESTASIS · RESTASIS MULTIDOSE · Rhopressa · SIMBRINZA · TEPEZZA · TRAVATAN Z · TYRVAYA · TearCare SmartLid · TobraDex ST · ULTRA · VEVYE · VUITY · VYZULTA · XDEMVY · XIIDRA · ZYLET · Zioptan · rhopressa · rocklatan
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

The majority of payments (67%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in optometrist and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 1% for optometrist in OH.

Looking for an optometrist in Cincinnati?
Compare optometrists in the Cincinnati area by procedure volume, costs, and industry payment transparency.
Browse optometrists nearby

Geographic Context

Optometrists within 10 mi
353
Per 100K population
42.6
County median income
$70,816
Nearest hospital
BETHESDA NORTH
2.6 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Zelczak is a clinical cardiology specialist, with above-average Medicare volume (top 14% in OH), with speaking/promotional industry engagement in the top 1% of OH peers, with 19 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Zelczak experienced with visual field test, extended?
Based on Medicare claims data, Dr. Zelczak performed 243 visual field test, extended services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Zelczak receive payments from pharmaceutical companies?
Yes. Dr. Zelczak received a total of $20,615 from 37 companies across 267 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Zelczak's costs compare to other optometrists in Cincinnati?
Dr. Zelczak's average Medicare payment per service is $40. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Zelczak) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →